Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies

Journal of the Neurological Sciences

Volumn 220, Issue 1-2, 2004, Pages 127-129

  Latov, Norman ^a   Renaud, Susanne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD2 ANTIGEN; CD59 ANTIGEN; COMPLEMENT RECEPTOR; CYTOKINE; FAS LIGAND; FC RECEPTOR; GAMMA INTERFERON; GANGLIOSIDE; GLYCOLIPID; GLYCOPROTEIN; GRANZYME B; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; NITRIC OXIDE; OXYGEN RADICAL; PERFORIN; PROTEIN ANTIBODY; PROTEINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL INTERACTION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COMPLEMENT FIXATION; CONFERENCE PAPER; DEMYELINATING NEUROPATHY; DNA MICROARRAY; ENDONEURIUM; ENDOTHELIUM CELL; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; MACROPHAGE; NATURAL KILLER CELL; NERVE BIOPSY; NERVE FIBER; NERVE FIBER DEGENERATION; PERIPHERAL NERVE; PHAGOCYTOSIS; PLASMA CELL; PRIORITY JOURNAL; SCHWANN CELL; SURAL NERVE; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; DEMYELINATING DISEASES; HUMANS; MACROPHAGES; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; SCHWANN CELLS; T-LYMPHOCYTES;

EID: 2442417565     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.03.012     Document Type: Conference Paper

References (41)

1. Nukada H., McMorran P.D., Shimizu J. Acute inflammatory demyelination in reperfusion nerve injury. Ann. Neurol. 47:2000;71-79
2. Kiefer R., Kieseier B.C., Stoll G., Hartung H.P. The role of macrophages in the immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64:2001;109-127
3. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599
4. Uncini A., Di Muzio A., Di Guglielmo G., et al. Effect of rhTNFalpha injection into rat sciatic nerve. J. Neuroimmunol. 95:1999;88-94
5. Hall S.M., Redford E.J., Smith K.J. Tumour necrosis factor-alpha has few morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous system. J. Neuroimmunol. 106:2000;130-136
6. Weishaupt A., Bruck W., Hartung T., et al. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha. Neurosci. Lett. 306:2001;77-80
7. Van Rhijn I., van den Berg L.H., Bosboom W.M., et al. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain. 123:2000;2020-2029
8. Andorfer B., Kieseier B.C., Mathey E., et al. Expression and distribution of transcription factor NF-κB and inhibitor IκB in the inflamed peripheral nervous system. J. Neuroimmunol. 116:2001;226-232
9. Kiefer R., Dangond F., Mueller M., et al. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J. Neurol. Neurosurg. Psychiatry. 69:2000;362-368
10. Schmidt B., Toyka K.V., Kiefer R., et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 19:1996;474-487
11. Sommer C., Lindenlaub T. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol. (Berl). 105:2003;593-602
12. Wanschitz J., Maier H., Lassmann H., et al. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome. Brain. 126:2003;2034-2042
13. Reichert F., Rotshenker S. Complement-receptor-3 and scavenger-receptor- AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol. Dis. 12:2003;65-72
14. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 125:2002;2591-2625
15. Dalakas M.C., Engel W.K. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch. Neurol. 37:1980;637-640
16. Hays A.P., Lee S.S., Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J. Neuroimmunol. 18:1988;231-244
17. Matsumuro K., Izumo S., Umehara F., Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J. Neurol. Sci. 127:1994;170-178
18. Quattrini A., Comi G., Nemni R., et al. Axonal neuropathy associated with interferon alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol. (Berl.). 94:1997;504-508
19. Murata K., Dalakas M.C. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain. 123:2000;1660-1666
20. Oliveira R.B., Ochoa M.T., Sieling P.A., et al. Expression of toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect. Immun. 71:2003;1427-1433
21. Bonetti B., Valdo P., Ossi G., et al. T-cell cytotoxicity of human Schwann cells: TNF alpha promotes fasL-mediated apoptosis and IFN-gamma perforin-mediated lysis. Glia. 43:2003;141-148
22. Renaud S., Hays A.P., Brannagan T.H., et al. Gene expression profiling in vasculitis and normal nerve. Neurology. 62(Suppl. 5):2004;A341-A342
23. Taylor J.M., Pollard J.D. Neurophysiological changes in demyelinating and axonal forms of acute experimental allergic neuritis in the Lewis rat. Muscle Nerve. 28:2003;344-352
24. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann. Neurol. 37(Suppl. 1):1995;S32-S42
25. Mendell J.R., Sahenk Z., Whitaker J.N., et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin associated glycoprotein antibody. Ann. Neurol. 17:1985;243-254
26. Weiss M.D., Dalakas M.C., Lauter C.J., et al. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. J. Neuroimmunol. 95:1999;174-184
27. Ogino M., Tatum A.H., Latov N. Affinity studies of human anti-MAG antibodies in neuropathy. J. Neuroimmunol. 52:1994;41-46
28. Gabriel J.M., Erne B., Bernasconi L., et al. Confocal microscopic localization of anti-myelin associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol. (Berl.). 95:1998;540-546
29. Takatsu M., Hays A.P., Latov N., et al. Immunofluorescence study of patients with neuropathy and IgM M proteins. Ann. Neurol. 18:1985;173-181
30. Vital C., Vital A., Deminiere C., Julien J., et al. Myelin modifications in 8 cases of peripheral neuropathy with Waldenstrom's macroglobulinemia and anti-MAG activity. Ultrastruct. Pathol. 21:1997;509-516
31. Ritz M.F., Erne B., Ferracin F., Vital A., Vital C., Steck A.J. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve. 22:1999;1030-1037
32. Monaco S., Bonetti B., Ferrari S., et al. Complement mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N. Engl. J. Med. 322:1990;649-652
33. Gabriel J.M., Erne B., Miescher G.C., et al. Selective loss of myelin-associated glycoprotein correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain. 119:1996;775-787
34. Fruttiger M., Montag D., Schachner M., Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of the axon-myelin integrity. Eur. J. Neurosci. 7:1995;511-515
35. Lunn M.P., Crawford T.O., Hughes R.A., et al. Anti-myelin associated glycoprotein antibodies alter neurofilament spacing. Brain. 125:2002;904-911
36. Younger D.S., Rosoklija G., Hays A.P., et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve. 19:1996;722-727
37. Hays A.P., Latov N., Takatsu M., Sherman W.H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 37:1987;242-256
38. Willison H.J., Trapp B.D., Bacher J.D., et al. Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve. 11:1988;1169-1176
39. Monaco S., Ferrari S., Bonetti B., et al. Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complexes. J. Neuropathol. Exp. Neurol. 54:1995;96-104
40. Tatum A.H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin associated glycoprotein. Ann. Neurol. 33:1993;502-506
41. Latov N. Prognosis of neuropathy with monoclonal gammopathy. Muscle Nerve. 23:2000;150-152